Galletta Vivian, Azevedo Luciane, Lodi Giovanni, Migliari Dante
Clinic for Lasers in Dentistry (LELO), School of Dentistry University of Sao Paulo, Sao Paulo, Brazil.
Unit of Oral Medicine and Pathology, Department of Surgical Medicine and Dentistry, University of the Studies of Milan Milan, Italy.
J Contemp Dent Pract. 2017 Sep 1;18(9):775-780. doi: 10.5005/jp-journals-10024-2125.
To analyze factors that may affect recurrence, development of new lesions, and malignant transformation in patients with oral leukoplakia (OL) following surgical treatment with lasers.
A total of 40 patients were enrolled in this study, 17 females (mean age of 64.5 years; 33-88 years) and 23 males (mean age of 56.6 years; 28-84 years) with an overall mean age of 60.5 years. A total of 49 lesions were diagnosed and treated; 9 patients had more than one site affected. Mean time of follow-up was 22 months (6-71 months). Data were assessed by univariate Cox and multivariate Cox regression analyses.
Recurrence (OL at the same site of the initial lesion) was observed in 11 patients (27.5%) while 4 patients (10%) developed new lesions, and 2 patients (5%) experienced malignant transformation. Only two clinical factors were statistically associated with the outcome for the development of new lesions: patients ≥ 60 years and female gender (p < 0.1). Neither of the outcomes of recurrences and malignant transformations was significantly correlated with any of the risk factors analyzed.
Surgical laser is not a deterrent for the outcomes evaluated; additionally, the design of this study did not allow us to determine whether the laser treatment had provided a great benefit by significantly reducing the rate of malignant transformation among the patients.
It is highly important to inform patients with OL that their condition can be treated, when possible, by surgical laser, and that this treatment may be helpful in bringing down the odds of malignant transformation of their lesions. In addition, the patients should also be brought to the attention of the necessity of a continued clinical monitoring regardless of the outcome following a surgical intervention.
分析口腔白斑(OL)患者接受激光手术治疗后可能影响复发、新病变发生及恶变的因素。
本研究共纳入40例患者,其中女性17例(平均年龄64.5岁,33 - 88岁),男性23例(平均年龄56.6岁,28 - 84岁),总体平均年龄60.5岁。共诊断并治疗49个病变;9例患者有多个部位受累。平均随访时间为22个月(6 - 71个月)。通过单因素Cox和多因素Cox回归分析评估数据。
11例患者(27.5%)出现复发(初始病变部位出现OL),4例患者(10%)出现新病变,2例患者(5%)发生恶变。仅两个临床因素与新病变发生的结果有统计学关联:年龄≥60岁和女性性别(p < 0.1)。复发和恶变的结果均与所分析的任何风险因素无显著相关性。
手术激光对所评估的结果并非阻碍因素;此外,本研究设计不允许我们确定激光治疗是否通过显著降低患者恶变率而带来了巨大益处。
告知OL患者其病情在可能的情况下可通过手术激光治疗,且这种治疗可能有助于降低其病变恶变几率非常重要。此外,还应让患者注意到,无论手术干预结果如何,持续临床监测的必要性。